ProcureHub · Indirect & Services · Global

Biologics Drug Product Manufacturing CMO: Market Size & Forecast 2026

The global biologics drug product manufacturing CMO market sits at approximately USD 52 billion in 2025 (base year), held in a structurally tight balance between accelerating biologics pipeline demand, constrained GMP fill-finish capacity in key Western markets, and a multi-year capacity build-out across Asia-Pacific contract manufacturers. The segment encompasses drug product manufacturing services for biologics, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies, with fill-finish and packaging representing the critical capacity constraint for near-term supply chain resilience. > Synthesised from secondary and publicly verifiable sources via Claight Category Watch:

Market size · 2025
$0.00bn
CAGR · 2025–2030
11%
Forecast · 2030
$0.00bn
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and CAGR extracted from the published Claight report; figures match the report..
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2025 base: $0.0bn2032 est: $0.0bn
Read the full Biologics Drug Product Manufacturing CMO report →
Talk to a Claight analyst
Do you want to research Biologics Drug Product Manufacturing CMO?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.